{"acquisitions":[],"changes":[],"country":"GB","description":"Laverock Therapeutics develops programmable advanced therapies using RNA-based gene-control and cell-engineering platforms. It serves patients with unmet needs in oncology and beyond, plus partners across applications. Its disease-responsive systems fine-tune gene expression dynamically rather than using simple on/off switches.","domain":"laverocktx.com","employees":null,"founded":2021,"fundingTotalQuarantined":false,"githubOrg":null,"githubStars":null,"industry":"unknown","industrySources":[],"investors":[],"lat":51.507446,"lng":-0.127765,"location":"London, United Kingdom","multiples":[],"name":"Laverock Therapeutics","people":[],"revenues":[],"rounds":[{"amountQuarantined":false,"amountUsd":25164000,"connectionsAmong":[],"currency":"EUR","date":"2025-06-01","investments":[],"investors":[],"leadInvestor":null,"leadInvestors":[],"people":[],"slug":"laverocktx-com-2025-06-01-seed","source":{"fact":"round","publisher":"eu-startups","retrievedAt":"2026-05-08","status":"attributed","url":null},"status":"attributed","type":"seed","url":null}],"slug":"laverocktx-com","sources":[{"fact":"round","publisher":"eu-startups","retrievedAt":"2026-05-08","status":"attributed","url":null},{"fact":"existence","publisher":"laverocktx.com","retrievedAt":"2026-05-08","status":"self-reported","url":"https://laverocktx.com"},{"fact":"description","publisher":"laverocktx.com","retrievedAt":"2026-05-08","status":"self-reported","url":"https://laverocktx.com"}],"stage":"seed","stockCard":{"asOf":"2026-11-09","facts":[],"generatedAt":"2026-11-09","state":"insufficient-evidence","tldr":[]},"techStack":["Cloudflare","LottieFiles 5.12.2","Google Font API","Google Hosted Libraries","Google Tag Manager","jquery 3.5.1"],"totalRaisedUsd":25920000,"traction":[],"updatedAt":"2026-05-08","valuations":[]}